Takeda Pharmaceuticals has decided to wrap up the remaining Actos linked bladder cancer lawsuits. Takeda settled two more claims this week, after a two-month trial in Nevada state court.
Recently, Takeda ear-marked $2.4 billion for settlements to settle thousands of personal injury and defective product liability lawsuits brought by diabetic patients who were diagnosed with bladder cancer after using Actos.
Actos Settlement Band Wagon Keeps On Rolling
In September, Takeda said that 96% of Actos claimants signed up for its $2.3 billion settlement offer, settling most of the 8,000 plus cases pending in state and federal courts.
On other fronts, Takeda settled the 7 out of 9 cases that had been tried and were up on appeal. Takeda also agreed to toss in an extra $100 million if 97% of claims matched up with settlement criteria. Takeda is trying close down the Actos bladder litigation, by encouraging as many plaintiffs as possible to settle their injury claims and keep the settlement band wagon rolling on.